title: Bromocriptine and amantadine in cocaine detoxification.
abstract: The effects of bromocriptine and amantadine in treating cocaine withdrawal were compared. Withdrawal symptoms are thought to be due to central dopamine depletion. Both bromocriptine and amantadine are dopamine agonists previously reported to diminish withdrawal symptoms. Thirty subjects were withdrawn for 30 days with amantadine, bromocriptine, or placebo. Bromocriptine and amantadine were more effective than placebo for 15 days. Amantadine's effectiveness then declined so that it was no more effective than placebo by experiment's end. Bromocriptine was significantly more effective than both throughout the latter phase of the study. Amantadine's decline in effectiveness is hypothesized to be due to stimulation of dopamine release.
authors.affiliation: Northeastern Ohio University College of Medicine, Columbus.
authors.forename: A J
authors.initials: AJ
authors.lastname: Giannini
authors.forename: D J
authors.initials: DJ
authors.lastname: Folts
authors.forename: J N
authors.initials: JN
authors.lastname: Feather
authors.forename: B S
authors.initials: BS
authors.lastname: Sullivan
mesh_terms: D000328:Adult; D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects; D001971:Bromocriptine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003042:Cocaine / Q000009:adverse effects; D006801:Humans; D008297:Male; D011897:Random Allocation; D011954:Receptors, Dopamine / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000534:rehabilitation; D019966:Substance-Related Disorders / Q000534:rehabilitation*
chemical_list: D011954:Receptors, Dopamine; D001971:Bromocriptine; D000547:Amantadine; D003042:Cocaine